tiprankstipranks
Eli Lilly raises FY24 adjusted EPS view to $13.50-$14.00 from $12.20-$12.70
PremiumThe FlyEli Lilly raises FY24 adjusted EPS view to $13.50-$14.00 from $12.20-$12.70
2d ago
Eli Lilly reports Q1 EPS $2.58, consensus $2.46
PremiumThe Fly
Eli Lilly reports Q1 EPS $2.58, consensus $2.46
2d ago
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
PremiumPress Releases
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
2d ago
LLY vs. JNJ: Which Big Pharma Stock Is Better?
PremiumMarket NewsLLY vs. JNJ: Which Big Pharma Stock Is Better?
7d ago
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans
PremiumMarket News
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans
9d ago
Influencers are talking up weight loss drugs, but omit side effects, WSJ says
PremiumThe Fly
Influencers are talking up weight loss drugs, but omit side effects, WSJ says
13d ago
Inspire rises, ResMed slips as Street digests data from Lilly sleep apnea trials
PremiumThe FlyInspire rises, ResMed slips as Street digests data from Lilly sleep apnea trials
14d ago
KeyBanc views Lilly’s SURMOUNT-OSA results as ‘a bit of a relief’ for Inspire
PremiumThe Fly
KeyBanc views Lilly’s SURMOUNT-OSA results as ‘a bit of a relief’ for Inspire
14d ago
Lilly OSA results ‘small net-positive’ for Inspire Medical, says Morgan Stanley
PremiumThe Fly
Lilly OSA results ‘small net-positive’ for Inspire Medical, says Morgan Stanley
14d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100